GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Omnicare Inc (FRA:OMN) » Definitions » Intangible Assets

Omnicare (FRA:OMN) Intangible Assets : €3,748 Mil (As of Jun. 2015)


View and export this data going back to . Start your Free Trial

What is Omnicare Intangible Assets?

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Omnicare's intangible assets for the quarter that ended in Jun. 2015 was €3,748 Mil.


Omnicare Intangible Assets Historical Data

The historical data trend for Omnicare's Intangible Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnicare Intangible Assets Chart

Omnicare Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Intangible Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,422.27 3,409.25 3,393.82 3,056.82 3,374.37

Omnicare Quarterly Data
Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15
Intangible Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,072.69 3,233.68 3,374.37 3,845.73 3,748.13

Omnicare Intangible Assets Calculation

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Examples of intangible assets include trade secrets, copyrights, patents, trademarks. If a company acquires assets at the prices above the book value, it may carry goodwill on its balance sheet. Goodwill reflects the difference between the price the company paid and the book value of the assets.


Omnicare  (FRA:OMN) Intangible Assets Explanation

If a company (company A) received a patent through their own work, though it has value, it does not show up on its balance sheet as an intangible asset. However, if company A sells this patent to company B, it will show up on company B's balance sheet as an intangible asset.

The same applies to brand names, trade secrets etc. For instance, Coca-Cola's brand is extremely valuable, but the brand does not appear on its balance sheet, because the brand was never acquired.

Some intangibles are amortized. Amortization is the depreciation of intangible assets.

Many intangibles are not amortized. They may still be written down when the company decides the asset is impaired.

Whenever you see an increase in goodwill over a number of years, you can assume it's because the company is out buying other businesses above book value. GOOD if buying businesses with durable competitive advantage.

If goodwill stays the same, the company when acquiring other companies is either paying less than book value or not acquiring. Businesses with moats never sell for less than book value.

Intangibles acquired are on balance sheet at fair value.

Internally developed brand names (Coke, Wrigleys, Band-Aid) however are not reflected on the balance sheet.

One of the reasons competitive advantage power can remain hidden for so long.


Be Aware

Companies may change the way intangible assets are amortized, and this will affect their reported earnings.


Omnicare Intangible Assets Related Terms

Thank you for viewing the detailed overview of Omnicare's Intangible Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Omnicare (FRA:OMN) Business Description

Traded in Other Exchanges
N/A
Address
Omnicare Inc was formed in 1981 in Delaware. It is a healthcare services company that specializes in the management of complex pharmaceutical care. The Company operates two primary businesses, Long-Term Care Group and Specialty Care Group. Through Long-Term Care Group, the Company provides pharmaceuticals and related pharmacy services to long-term care facilities as well as chronic care facilities and other settings. Through Specialty Care Group, the Company provides specialty pharmacy and commercialization services for the biopharmaceutical industry. The Company's businesses engage in an ongoing program for the development and marketing of new services. The Company serves long-term care institutions and other chronic care settings in approximately 47 states in the U.S. and the District of Columbia. The Company's largest competitor nationally is PharMerica Corporation. It also competes with numerous local and regional institutional pharmacies, pharmacies owned by long-term care facilities and local retail pharmacies. The Company is subject to extensive federal, state and local regulation.